Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Stack

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|July 1, 2015
Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate CancerNeil E Martin, Travis Gerke, Jennifer A Sinnott, et al.
BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.
Pathology, Research and Practice|July 31, 2025
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasiaFrancesca Khani, Shaham Beg, Kyung Park, et al.
Blood|September 13, 2017
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphomaChristopher D Carey, Daniel Gusenleitner, Mikel Lipschitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancerSun Yoo, Andreas Pettersson, Kristina M Jordahl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 miceEdward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlatesToni K Choueiri, Susanna Jacobus, Joaquim Bellmunt, et al.
Nature Genetics|September 5, 2020
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|July 1, 2015
Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate CancerNeil E Martin, Travis Gerke, Jennifer A Sinnott, et al.
BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.
Pathology, Research and Practice|July 31, 2025
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasiaFrancesca Khani, Shaham Beg, Kyung Park, et al.
Blood|September 13, 2017
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphomaChristopher D Carey, Daniel Gusenleitner, Mikel Lipschitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancerSun Yoo, Andreas Pettersson, Kristina M Jordahl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 miceEdward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlatesToni K Choueiri, Susanna Jacobus, Joaquim Bellmunt, et al.
Nature Genetics|September 5, 2020
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Journal of the National Cancer Institute|December 3, 2013
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERGAndreas Pettersson, Rosina T Lis, Allison Meisner, et al.
Pageof 5